Flyer

Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 24
  • Journal CiteScore: 8.01
  • Journal Impact Factor: 7.55
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Probiotics and Application of Saccharomycesis bulardii As a probiotic Probiotics

3rd Intercontinental Conference on Microbiology and Infectious Diseases
March 02-03, Webinar | Webinar

Elham Taghinia

Islamic Azad University, Iran

Scientific Tracks Abstracts: Arch of Clin Micro

Abstract:

Introduction: Probiotics are beneficial bacteria in the microbial flora of the gastrointestinal tract. Literally, the root of the word probiotic is Greek, but in fact the word consists of the Latin prefix “Peru” and the ancient Greek word “bios”, a combination of the word meaning “for life”. The introduction of this concept is generally attributed to the Nobel Laureate “Alimchenikov”, who in 1907 proposed that “the dependence of intestinal microbes on food intake makes it possible to change the microbial population living in the human body and microbes “Replace harmful microbes with beneficial ones. Introduction: “The World Health Organization refers Probiotic term as “living organisms” that, if consumed in sufficient quantities, provide “health” effects to their hosts. Probiotics can contain many different types of microorganisms, but the most common are Lactobacillus and Bifidobacterium.In addition to the mentioned groups, yeasts can also have probiotic properties. In this article, the probiotic properties of Saccharomyces boulardii yeast are mentioned. Henry Bollard first isolated a strain of yeast from tropical fruits and Called it Saccharomycesis bulardii .Nowadays it is the only commercialized probiotic yeast. In the early twentieth century, probiotics were thought to improve microbial balance, intestinal and prevention of pathogenic bacteria and toxins have benefits for the host body. Detailed and documented studies are being conducted today to determine the effects Special probiotics include relief of chronic inflammatory bowel disease, colon cancer, prevention and treatment of diarrheal diseases, Urinary and genital tract infections, a group of allergies and irritable bowel syndrome include chronic intestinal inflammation. Discussion: Saccharomyces boulardii, a non-pathogenic yeast when used as a probiotic, has been shown to be effective in the prevention and/or treatment of intestinal disorders, including antimicrobial- associated diarrhea, recurrent Clostridium difficile disease, acute diarrhea in adults and children induced by a variety of enteric pathogens, traveler’s diarrhea and relapses of Crohn’s disease or ulcerative colitis. The aim of the present study was to assess the virulence and the potential dissemination of the extensively used, commercially available strain of S. boulardii, when given orally in different doses in an experimental mouse model. In addition, we wanted to investigate the effects of S. boulardii on the gastrointestinal (GI) colonization by C. albicans in an established experimental model which successfully mimics the function of the human gut. Keywords: probiotics, Saccharomyces boulardii, potentially probiotic yeasts, gastrointestinal (GI)